3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Thyroid Diseases
1
Parathyroid Diseases
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Surveys and Questionnaires
4
Nivolumab
3
pembrolizumab
2
cemiplimab
2
atezolizumab
2
amminedichloro(2-methylpyridine)platinum(II)
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
trametinib
1
repotrectinib
1
pralsetinib
1
pazopanib
1
motexafin gadolinium
1
durvalumab
1
dabrafenib
1
avelumab
1
alectinib
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiosurgery
1
Quality of Life
1
Patient-Specific Modeling
1
Oncolytic Virotherapy
1
Ocoxin
1
Observation
1
Mass Screening
1
MLN 8237
1
Immune Checkpoint Inhibitors
1
Hyperspectral Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Hyperspectral Imaging
×
Head & Neck
×
Clear all
NCT04589884
2024-01-09
iEXMachyna3
IHU Strasbourg
Terminated
112 enrolled